Literature DB >> 20036519

Susceptibility patterns and molecular epidemiology of multidrug-resistant Acinetobacter baumannii strains from three military hospitals in China.

Zhong-Qiang Yan1, Ding-Xia Shen, Jing-Rong Cao, Rong Chen, Xing Wei, Li-Ping Liu, Xiu-Li Xu.   

Abstract

To date, little has been reported on the susceptibility patterns and molecular characterisation of multidrug-resistant Acinetobacter baumannii (MDRAB) clinical isolates from different Chinese military hospitals. In this study, 49 MDRAB strains were collected from three military hospitals during 2007. The minimum inhibitory concentrations (MICs) of 13 antibiotics were determined for each strain. Genotyping and dendrogram analysis of MDRAB strains were performed using the repetitive sequence-based polymerase chain reaction (rep-PCR) DiversiLab Microbial Typing System. PCR screening was carried out to investigate the distribution of various genes contributing to each resistance phenotype in the main clonal types. The rates of resistance to the majority of antibiotics tested varied between 75.5% and 100%, with the exception of polymyxin B. Two DiversiLab rep-PCR clones (A and B) were widespread in three hospitals in different cities, one clone (D) existed only in two hospitals located in the same city (Beijing), and the other two clones (C and E) were present in only one hospital. In addition, this study shows a high distribution of intI1, ISAba1, bla(OXA-23), bla(ADC), adeB, adeJ, abeM and tet(B) genes, which mediate resistance to structurally unrelated antimicrobials in MDRAB isolates. These results suggest that all isolates were resistant to at least three classes of antibiotics. In addition, clonal dissemination among the three hospitals located in two different cities in China, previously documented in many regions of Europe and Asia-Pacific nations, emphasises the epidemic potential of these MDRAB isolates. Copyright 2009 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036519     DOI: 10.1016/j.ijantimicag.2009.10.016

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  11 in total

1.  Interlaboratory reproducibility of DiversiLab rep-PCR typing and clustering of Acinetobacter baumannii isolates.

Authors:  Paul G Higgins; Andrea M Hujer; Kristine M Hujer; Robert A Bonomo; Harald Seifert
Journal:  J Med Microbiol       Date:  2011-09-08       Impact factor: 2.472

Review 2.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

3.  [Usefulness of MALDI-TOF and REP-PCR against PFGE for the epidemiological study of Acinetobacter baumannii].

Authors:  C García-Salguero; E Culebras; A Alvarez-Buylla; I Rodríguez-Avial; A Delgado-Iribarren
Journal:  Rev Esp Quimioter       Date:  2021-04-08       Impact factor: 1.553

4.  Complete genome analysis of three Acinetobacter baumannii clinical isolates in China for insight into the diversification of drug resistance elements.

Authors:  Lingxiang Zhu; Zhongqiang Yan; Zhaojun Zhang; Qiming Zhou; Jinchun Zhou; Edward K Wakeland; Xiangdong Fang; Zhenyu Xuan; Dingxia Shen; Quan-Zhen Li
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

5.  Antimicrobial Susceptibility and Clonal Relation Between Acinetobacter baumannii Strains at a Tertiary Care Center in Turkey.

Authors:  Gulfem Ece; Bayri Erac; Hasan Yurday Cetin; Cem Ece; Aysegul Baysak
Journal:  Jundishapur J Microbiol       Date:  2015-02-20       Impact factor: 0.747

6.  Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran.

Authors:  Saeed Shoja; Mojtaba Moosavian; Amir Peymani; Mohammad Amin Tabatabaiefar; Soodabeh Rostami; Nasim Ebrahimi
Journal:  Iran J Microbiol       Date:  2013-12

7.  Rapid detection of Acinetobacter baumannii and molecular epidemiology of carbapenem-resistant A. baumannii in two comprehensive hospitals of Beijing, China.

Authors:  Puyuan Li; Wenkai Niu; Huan Li; Hong Lei; Wei Liu; Xiangna Zhao; Leijing Guo; Dayang Zou; Xin Yuan; Huiying Liu; Jing Yuan; Changqing Bai
Journal:  Front Microbiol       Date:  2015-09-23       Impact factor: 5.640

8.  Rapid molecular characterization of Acinetobacter baumannii clones with rep-PCR and evaluation of carbapenemase genes by new multiplex PCR in Hospital District of Helsinki and Uusimaa.

Authors:  Tanja Pasanen; Suvi Koskela; Sointu Mero; Eveliina Tarkka; Päivi Tissari; Martti Vaara; Juha Kirveskari
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

9.  Molecular Epidemiology of Carbapenem-Resistant Acinetobacter Baumannii Complex Isolates from Patients that were Injured During the Eastern Ukrainian Conflict.

Authors:  Heike Granzer; Ralf Matthias Hagen; Philipp Warnke; Wolfgang Bock; Tobias Baumann; Norbert Georg Schwarz; Andreas Podbielski; Hagen Frickmann; Thomas Koeller
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-05-17

10.  Characterization of Oxacillinase and Metallo-β-Lactamas Genes and Molecular Typing of Clinical Isolates of Acinetobacter baumannii in Ahvaz, South-West of Iran.

Authors:  Saeed Shoja; Mojtaba Moosavian; Soodabeh Rostami; Fariba Abbasi; Mohammad Amin Tabatabaiefar; Amir Peymani
Journal:  Jundishapur J Microbiol       Date:  2016-02-13       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.